Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Oblique Therapeutics AB (publ)

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 60 More Arrow 2,034 Less Arrow 280
Earnings before taxes -61,929 More Arrow -53,547 Less Arrow -61,640
EBITDA -37,765 Less Arrow -48,231 Less Arrow -58,247
Total assets 18,561 Less Arrow 18,176 More Arrow 30,836
Current assets 16,169 Less Arrow 8,107 More Arrow 22,300
Current liabilities 6,122 More Arrow 11,261 Less Arrow 9,554
Equity capital 11,589 Less Arrow 3,363 More Arrow 19,727
- share capital 1,826 Less Arrow 759 Equal arrow 759
Employees (average) 18 Equal arrow 18 Less Arrow 16

Financial ratios

Fiscal year 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 62.4% Less Arrow 18.5% More Arrow 64.0%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -333.3% More Arrow -283.4% More Arrow -199.0%
Current ratio 264.1% Less Arrow 72.0% More Arrow 233.4%
Return on equity (ROE) -534.4% Less Arrow -1592.2% More Arrow -312.5%
Change turnover
Change turnover % -100%
Chg. No. of employees
Chg. No. of employees % 13% More Arrow 33%

Total value of public sale

Fiscal year 2023/12 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.